Related Experiment Videos
Warm heart surgery and results of operation for recent myocardial infarction
S V Lichtenstein1, J G Abel, T A Salerno
1Division of Cardiovascular Surgery, St. Michael's Hospital, Toronto, Ontario, Canada.
Insights
Warm aerobic arrest during coronary artery bypass grafting significantly reduces mortality and complications in patients with recent myocardial infarction compared to cold cardioplegia. This technique offers a safer approach for high-risk cardiac surgery patients.
Area of Science:
- Cardiovascular Surgery
- Cardiac Anesthesia
- Myocardial Protection
Background:
- Revascularization after myocardial infarction carries high risks.
- Conventional hypothermic cardioplegia can worsen myocardial injury.
- Cold cardioplegia may lead to anaerobic metabolism.
Purpose of the Study:
- To evaluate the efficacy of warm aerobic arrest versus cold cardioplegia for myocardial protection.
- To assess outcomes in patients undergoing coronary artery bypass grafting after acute myocardial infarction.
Main Methods:
- A nonrandomized study comparing 115 patients undergoing coronary artery bypass grafting.
- Myocardial protection using continuous cold (4°C) or warm (37°C) blood cardioplegia.
- Comparison of a historical cohort (cold) with a recent cohort (warm).
Main Results:
- Warm cardioplegia group showed 0% mortality versus 10.9% in the cold group (p<0.05).
- Myocardial infarction rate was 2.0% with warm cardioplegia vs. 9.3% with cold (p<0.05).
- Intraaortic balloon pump use was 0% for warm vs. 12.5% for cold (p<0.05).
Conclusions:
- Continuous warm aerobic arrest minimizes ischemia and anaerobic metabolism.
- Warm aerobic arrest offers significant benefits for patients with compromised myocardium.
- This technique may be a superior alternative to hypothermic arrest in high-risk patients.
Abstract:
Revascularization procedures after recent myocardial infarction are associated with higher mortality and morbidity compared with elective coronary artery bypass grafting. Traditional methods of myocardial protection impose a further ischemic insult on already compromised myocardium. Continuous cold blood cardioplegia may eliminate ischemia but may still leave the heart anaerobic. Theoretically, warm aerobic arrest addresses both of these issues and may become an attractive alternative to standard hypothermic ischemic arrest in this setting. In 115 nonrandomized patients undergoing coronary artery bypass grafting within 6 hours to 7 days of an acute myocardial infarction, myocardial protection was provided with continuous cold (4 degrees C) or continuous warm (37 degrees C) blood cardioplegia. Fifty-one patients (after 1988) protected with warm blood cardioplegia were compared with a historical cohort of 64 patients (before 1988) protected with cold blood cardioplegia. Results indicate that the warm cardioplegia group had no mortality versus 10.9% for the cold group (p less than 0.05), a myocardial infarction rate of 2.0% in the warm versus 9.3% in the cold group, and use of intraaortic balloon pump of 0% versus 12.5%, respectively (p less than 0.05). It is concluded that continuous warm aerobic arrest may minimize ischemia and anaerobic metabolism during the operative procedure, and may be of benefit to patients who have a limited tolerance to ischemic insult.